E
OGN icon

Ergoteles’s Organon & Co OGN Stock Holding History

Ergoteles’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-48,233
Closed -$1M – 588
2023
Q2 		$1M Buy
+48,233
New +$1.05M 0.05% 462
2023
Q1 		– Sell
-153,818
Closed -$4.3M – 1619
2022
Q4 		$4.3M Buy
153,818
+144,650
+1,578% +$3.7M 0.16% 133
2022
Q3 		$215K Buy
+9,168
New +$277K 0.01% 1141

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Ergoteles's OGN Position: Q3 2023 in Review

Ergoteles sold out of Organon & Co (OGN) in Q3 2023, closing a stake of 48,233 shares — an estimated $1M sold.

Ergoteles first reported a position in OGN in Q3 2022 and held it in 3 quarters. The position peaked at $4.3M in Q4 2022. 730 funds tracked by Wall St. Rank hold OGN as of Q3 2023.

  • Ergoteles reported no remaining Organon & Co position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 48,233 Organon & Co shares in Q3 2023, an estimated $1M.
  • Ergoteles first reported a position in Organon & Co in Q3 2022 and held it in 3 quarters.
  • Ergoteles's Organon & Co position peaked at $4.3M in Q4 2022.
  • 730 funds tracked by Wall St. Rank held Organon & Co as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.